Fact.MR – A Market Research and Competitive Intelligence Provider: The global viral antigens market is expected to grow at a robust pace during the forecast period between 2020 to 2025, predicts Fact.MR.
North America and Europe to be the Epicenter for Viral Antigens Market, Contributing 70% of Sales
In its new study, Fact.MR provides in-depth information about various aspects of the global viral antigens market. It highlights major opportunities, growth drivers, and restraints across major segments including component, technique, end-user, and region. Besides, it offers the latest industry developments and various strategies adopted by key players.
Fact.MR – A Market Research and Competitive Intelligence Provider: The global viral antigens market is expected to grow at a robust pace during the forecast period between 2020 to 2025, predicts Fact.MR. Ongoing advancements in informatics platforms and image analysis software for detecting viral antigens are anticipated to drive the market in the near future.
Viral antigens are toxic substances or poisons administered by the virulent entities. These often produce an immune reaction in the host. Viral antigen detection tests are performed on a wide variety of specimens for influenza, dengue, and other viral diseases.
As per Fact.MR, the development of vaccines for various viral diseases includes the distribution of antigens. These further induce virus-specific neutralizing antibodies for preventing the induction of off-target antibodies.
If You Want To Know More About The Report @
https://www.factmr.com/connectus/sample?flag=S&rep_id=1305
In terms of technique, electron microscopy workflow is one of the most recently developed viral antigen techniques. It is capable of determining the localization of antigens within vaccines and viruses. Increasing awareness among researchers about the advantages of using this technique in vaccine research is set to propel the growth in this market.
“Emergence of multiple imaging modes is set to help researchers in capturing high-definition images and videos during the viral antigens immunogenicity analysis. Apart from this, advanced automated tools would enable researchers to produce images for differential cell analysis, thereby propelling growth,” says a Fact.MR analyst.
Key Takeaways:
- By technique, the ELISA segment is expected to dominate with 8.2% CAGR owing to its increasing usage in identifying viral antigens.
- The electron microscopy segment is anticipated to exhibit 9.4% CAGR as this technique is used in finding the structural organization of viral antigens.
- In terms of end-user, the diagnostic centers segment is likely to remain at the forefront in the near future.
- Based on component, the coronavirus antigens segment is set to hold the lion’s share during the forecast period.
- The U.S. is projected to lead the North America market owing to the rapid development of the biomedical research infrastructure.
- Europe is likely to remain in the second position with the U.K. and Germany leading the market, owing to the increased funding for clinical research in the field of life science.
Growth Drivers:
- Increasing adoption of viral antigens by researchers and clinicians to develop vaccines is expected to propel the growth in this market.
- Ability of ELISA technique to produce recombinant viral proteins is anticipated to drive its demand and bolster the market.
Restraints:
- As recombinant viral antigens are less immunogenic than inactivated whole-virus vaccines, their demand may get hampered in the near future.
To learn more about Viral Antigens Market, you can get in touch with our Analyst at
https://www.factmr.com/connectus/sample?flag=AE&rep_id=1305
Competitive Landscape
The global market for viral antigens houses a large number of companies. They are introducing novel products to expand their portfolios and gain a competitive edge. Besides, some of the other players are focusing on bagging fast track approvals from government agencies for marketing their products.
For instance,
- May 2020: The U.S. FDA issued the EUA to Quidel Corporation for its Sofia 2 SARS Antigen FIA. It is a new category of test that can quickly detect protein particles on or within the coronavirus. The test is conducted by taking samples from the nasal cavity of patients.
- May 2020: Bio-Rad Laboratories, a U.S.-based developer of high-quality products for the clinical diagnostics market, bagged the EUA approval for its SARS-CoV-2 Total Ab test from the U.S. FDA. It is a blood-based test for identifying the antibodies created by the human body in response to COVID-19.
- July 2019: Creative Diagnostics, which is an American biotechnology company, introduced a new series of viral antigens. It will be used for biological research work, including HBV, coronavirus, dengue virus, HAV, adenovirus, EV71, Ebola virus, and coxsackievirus.
Key Players in the Viral Antigens Market Include:
- Creative Diagnostics
- OXGENE
- The Native Antigen Company
- Microbix Biosystems
- Aalto Bio Reagents Ltd.
- Rekom Biotech S.L
- BIO-Rad Laboratories Inc.
- Meridian Bioscience, Inc.
- LGC Limited
- Prospec-Tany Technogene Ltd.
- Advanced Biotechnologies Inc.
More Valuable Insights on Viral Antigens Market
Fact.MR provides an unbiased analysis of the viral antigens market, presenting historical demand data (2014-2019) and forecast statistics for the period from 2020-2025. The study divulges compelling insights on the global viral antigens market with a detailed segmentation on the basis of:
Component
- Influenza Viral Antigens
- Coronavirus Antigens
- Zika Virus Antigens
- Ebola Virus Antigens
- Dengue Virus Antigens
- Herpes Simplex Virus (HSV) Viral Antigens
- Rotavirus Viral Antigens
- Epstein-Barr Virus Antigens
- Hepatitis A-E Virus Antigens
- Parainfluenza Virus Antigens
- Measles Virus Antigens
- Adenovirus Viral Antigens
- Mumps/Parotitis Virus Antigens
- Varicella Zoster Virus (VZV) Antigens
- Others
Technique
- ELISA
- Immunoassay
- Hemagglutination
- Radioimmunoassay (RIA)
- Immunoperoxidase Staining
- Immunofluorescence
- Electron Microscopy
- Others
End-user
- Hospitals
- Clinics
- Laboratories
- Diagnostic Centers
- Blood Banks
- Research Institutes
Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Key Questions Covered in Viral Antigens Market Report
- The report offers insight into the viral antigens market demand outlook for 2020-2025.
- The market study also highlights projected sales growth for viral antigens market between 2020 and 2025.
- Viral antigens market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry.
- Viral antigens market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others.
Explore Fact.MR’s Coverage on the Healthcare Domain –
Respiratory Virus Vaccines Market Analysis - The respiratory virus vaccines industry has risen to the forefront as a result of the uncontrolled spread of COVID-19. Fact.MR’s new market analysis provides insights into the future and uncover hidden opportunities for market participants. Increasing R&D investments and activities are assisting the market’s exponential rise. Developing vaccinations could be the most important step toward preventing widespread viral illnesses and lowering the mortality rate linked with them. As a result of the current epidemic, demand for respiratory virus vaccines is likely to increase dramatically.
Influenza A/B Combo Testing Market Insights - The tremendous burden of a viral pandemic is driving the expansion of the global Influenza A/B combo testing market, resulting in a surge in demand for Influenza A/B combo testing. Influenza A/B combo testing accuracy, sensitivity, and advance diagnosis are always being improved by research and healthcare infrastructure. The market is being fueled further by increased awareness of the pandemic and early detection, as well as the government’s proactive aids and programming. The leading players are concentrating their efforts on developing novel Influenza A/B combo testing kits that are quick to diagnose large-scale samples.
Viral Disease Diagnosis Market Scope - Viral disease diagnosis entails calculating the amount of antigen or antigen-specific antibodies produced as a result of the immunological response. The surge in viral infections and illnesses is expected to fuel the growth of diagnostics. The fundamental challenge in detecting the virus is changes in the viral genome. As a result, diagnosing becomes tough. As a result, new approaches such as microarray techniques and fast tests are being developed. Increased research and development for the detection of the virus is predicted to drive global viral disease market.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000’s trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR